Mirum Advances Brelovitug in Phase 3 Hepatitis Delta Trial
Foster City, California, U.S., September 28, 2026 Mirum Pharmaceuticals has reported a significant clinical-development milestone for brelovitug, an investigational...
Cardiometabolic health
Advertisement
Eli Lilly Wins FDA Approval for Once-Weekly Onswik
Indianapolis, Indiana, U.S., September 24, 2026 Eli Lilly and Company has reached a major milestone in diabetes care following...
Leap Therapeutics Reports DKK1 Findings in CRC Study Results
Cambridge, Massachusetts, August 12, 2026 Leap Therapeutics has announced the publication of final results from its randomized Phase 2...
Function and NYU Partner on Early Disease Detection Research
Austin, Texas, August 12, 2026 Function Health has announced a research partnership with NYU Grossman School of Medicine to...
Antag Therapeutics Doses First Patient in Phase 2a Trial of AT7687
COPENHAGEN, Denmark, July 28, 2026 Antag Therapeutics announced that the first patient has been dosed in its Phase 2a...
Advertisements
Eli Lilly Reports Positive Phase 3 Retatrutide Results
INDIANAPOLIS, July 23, 2026 Eli Lilly and Company has announced positive topline results from the Phase 3 TRIUMPH-2 and...
Nabsys Appoints Alka Chaubey to Advance Genome Mapping
PROVIDENCE, Rhode Island, July 6, 2026 Nabsys 2.0, LLC, a pioneer in electronic genome mapping (EGM) technology, has appointed...
Matica Bio, VaxDome Partner on Next-Gen Antiviral Vaccines
COLLEGE STATION, Texas, July 6, 2026 Matica Biotechnology, Inc. (Matica Bio) has entered into a strategic partnership with VaxDome...
DarioHealth Expands Digital Care Through Arizona Insurer Deal
NEW YORK, July 6, 2026 DarioHealth Corp. has announced a significant expansion of its digital health platform through a...
Dimerix Licenses DMX-200 to Everest Medicines in Asia
MELBOURNE, Australia, June 16, 2026 Dimerix Limited has announced a landmark exclusive licensing agreement with Everest Medicines for the...
Advertisement
